Indian Pharmaceutical Alliance (IPA) has called for more clarity in the definitions of counterfeit and spurious drugs and necessary amendment to the Drugs and Cosmetics Act accordingly, if the country wants to deal tougher with the instances like recent seizure of fake drugs with 'made in India' labels in Nigeria but produced and exported from China.
The details can be read here.
No comments:
Post a Comment